Clinical Trial Update: Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT. [NA]

View source ↗

Summary

A clinical trial evaluating the Flow Cytometry FlowPath Lung Test as a non-invasive diagnostic to identify lung cancer in high-risk individuals with LDCT-detect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: bioAffinity Technologies Inc. | Conditions: Lung Cancer (Diagnosis) | NA | Status: RECRUITING